Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
EFPIA
Description:
A Brussels-based trade association representing the pharmaceutical industry in Europe, including companies involved in research and development of medicines.
Related topics:
Pharmaceutical industry and healthcare (20%),
Pharmaceutical Economics and Policy (15%)
Wikidata ID:
wiki/Q1376562
OpenAlex ID:
keywords/efpia
The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop
2013
·
E Manolis
, S Rohou
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
77
PDF
A survey on IVIVC/IVIVR development in the pharmaceutical industry – Past experience and current perspectives
2017
·
M.A. Nguyen
, T. Flanagan
, et al.
·
European Journal of Pharmaceutical Sciences
·
73
Innovative Medicines Initiative (IMI)
2008
·
Jadrijević-Mladar Takač
, Milena
·
Farmaceutski glasnik : glasilo Hrvatskog farmaceutskog društva
·
56
The Innovative Medicines Initiative: a Public Private Partnership Model to Foster Drug Discovery
2013
·
Elisabetta Vaudano
·
Computational and Structural Biotechnology Journal
·
43
Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury: Industry-led perspective from EFPIA members of the EU Innovative Medicines Initiative Drug Liver Injury Project, MIP DILI
2017
·
Richard J. Weaver
, Catherine Betts
, et al.
·
Expert Opinion on Drug Metabolism & Toxicology
·
41
The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level
2008
·
N. Kamel
, C. Compton
, et al.
·
European Respiratory Journal
·
32
PDF
Commentary on the MID3 Good Practices Paper
2017
·
Efthymios Manolis
, Jacob Brogren
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
28
PDF
Europe to boost development of new antimicrobial drugs
2012
·
Tony Kirby
·
The Lancet
·
21
Promoting the uptake of green and sustainable methodologies in pharmaceutical synthesis: CHEM21 education and training initiatives
2016
·
Louise Summerton
, Rick J. Taylor
, et al.
·
Sustainable Chemistry and Pharmacy
·
20
PDF
The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance
2011
·
Richard Bergström
·
Drug Resistance Updates
·
18
Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
2019
·
Slavka Baronikova
, Jim Purvis
, et al.
·
BMJ Evidence-Based Medicine
·
15
PDF
The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks
2022
·
Diana O'Rourke
, Nina Coll-Padrós
, et al.
·
Frontiers in Neurology
·
8
Modèles de partenariats Public-Privé en France et en Europe
2006
·
Jacques Demotes-Mainard
, Emmanuel Canet
, et al.
·
Therapies
·
8
Joint EFPIA/CHMP SWP workshop: the Emerging Use of Omic Technologies for Regulatory Non-Clinical Safety Testing
2005
·
Peter Kasper
, Gerry Oliver
, et al.
·
Pharmacogenomics
·
8
European New Safe and Innovative Medicines Initiatives: History and Progress (through December 2009)
2011
·
Ole J. Bjerrum
, Hans H. Linden
·
Cambridge University Press eBooks
·
7
An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
2022
·
Clare Lavery
, Joanne Emmott
, et al.
·
Pharmaceutical Medicine
·
6
PDF
What pharmacist Sini Eskola does at the European Federation of Pharmaceutical Industries and Associations (EFPIA)
2017
·
Pharmaceutical journal/The pharmaceutical journal
·
6
Drug industry pledge on access to trial data is met with scepticism
2013
·
A. O'Dowd
·
BMJ
·
6
Regulatory Modeling and Simulation Moves Into the Next Gear in Europe
2013
·
PH van der Graaf
·
CPT Pharmacometrics & Systems Pharmacology
·
6
PDF
The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report
2024
·
Anna M. G. Pasmooij
, Peter G. M. Mol
, et al.
·
Clinical Pharmacology & Therapeutics
·
5
Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe—An EFPIA View
2023
·
Iain Todd
, Ruediger Faust
, et al.
·
Clinical Therapeutics
·
5
PDF
Participating in innovative medicines initiative funded neurodegenerative disorder projects—An impact analysis conducted as part of the NEURONET project
2023
·
Claire Hawksworth
, Fatima Salih
, et al.
·
Frontiers in Neurology
·
5
A Review of the Contributions of Cross-discipline Collaborative European IMI/EFPIA Research Projects to the Development of Replacement, Reduction and Refinement Strategies
2018
·
Sarah Wolfensohn
·
Alternatives to Laboratory Animals
·
5
Industry and drug regulators disagree on which data should remain confidential
2013
·
N. Hawkes
·
BMJ
·
5
European drug industry concerned over proposed clinical-trial legislation
1997
·
Arthur Rogers
·
The Lancet
·
5
Show more works
View as search
Works count:
98
Citation count:
552
Year
Topic
Type